Veana Therapeutics, Inc. — Form D
Veana Therapeutics, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-21. The offering totals $2.0M, of which $542K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-21
- Form: D
- Accession: 0001741217-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $542K
- Remaining: $1.5M
- Minimum investment: $5K
- Investors: 9
- Date of first sale: 2018-05-11
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-312903
Issuer
- Name: Veana Therapeutics, Inc.
- CIK: 0001741217
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 9398 SW WASHINGTON STREET, PORTLAND, OR, 97225
- Phone: (503) 292-4065
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Rebecca F Akporiaye | Director | Portland, OR |
| Denis R Burger | Director | Portland, OR |
| Trent D Davis | Director | Portland, OR |
| Mark F Holifer | Director | Portland, OR |
| F Andrew Ray | Director | Portland, OR |
| Rebecca F Akporiaye | Executive Officer | Portland, OR |
| Mark F Holifer | Executive Officer | Portland, OR |
| Thomas E McChesney | Executive Officer | Portland, OR |
| Andrew D Thaler | Executive Officer | Portland, OR |
| EMMANUEL AKPORIAYE | Promoter | Portland, OR |
| Mark F Holifer | Promoter | Portland, OR |
| Andrew Ray | Director | Baltimore, MD |
| Sandra Shotwell | Director | Portland, OR |
| EMMANUEL AKPORIAYE | Director | Portland, OR |
| EMMANUEL AKPORIAYE | Executive Officer | Portland, OR |
| REBECCA AKPORIAYE | Director | Portland, OR |
| REBECCA AKPORIAYE | Executive Officer | Portland, OR |
| BRUCE RAMSEYER | Director | Portland, OR |
Other filings by this issuer (1)
More